Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery
- 1 January 2013
- journal article
- Published by Elsevier in Biomaterials
- Vol. 34 (4), 1289-1301
- https://doi.org/10.1016/j.biomaterials.2012.10.024
Abstract
No abstract availableKeywords
Funding Information
- NIH (RO1 CA121838, RO1 CA128486)
This publication has 42 references indexed in Scilit:
- Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivoJournal of Controlled Release, 2012
- Development of the Novel PEG-PE-Based Polymer for the Reversible Attachment of Specific Ligands to Liposomes: Synthesis and in Vitro CharacterizationBioconjugate Chemistry, 2011
- Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptidesBiomaterials, 2011
- Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer CellsSmall, 2009
- The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistanceBiomaterials, 2009
- PAMAM-RGD Conjugates Enhance siRNA Delivery Through a Multicellular Spheroid Model of Malignant GliomaBioconjugate Chemistry, 2009
- Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA deliveryJournal of Controlled Release, 2009
- Nonviral Methods for siRNA DeliveryMolecular Pharmaceutics, 2008
- Self-assembling micelle-like nanoparticles based on phospholipid–polyethyleneimine conjugates for systemic gene deliveryJournal of Controlled Release, 2008
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008